{
    "clinical_study": {
        "@rank": "80665", 
        "arm_group": [
            {
                "arm_group_label": "Noninvasive Cryolipolysis Device", 
                "arm_group_type": "Active Comparator", 
                "description": "The Zeltiq System is a noninvasive (not breaking the skin) device that reduces fat by freezing fat cells until they break apart."
            }, 
            {
                "arm_group_label": "High Intensity Focused Ultrasound Device", 
                "arm_group_type": "Active Comparator", 
                "description": "The LipoSonix System is a noninvasive ultrasound device, which can be used to selectively target and destroy fat tissue located deep under the skin."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the safety and effectiveness of the Zeltiq System\n      and LipoSonix System for fat reduction and improving body shape."
        }, 
        "brief_title": "A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Abdominal Fat", 
        "detailed_description": {
            "textblock": "At baseline visit, subjects who meet inclusion and exclusion criteria will be enrolled.\n      Subjects will be randomly assigned to receive Zeltiq treatment to either their right or left\n      flank The contralateral flank will receive Liposonix treatment. A total of three identical\n      treatments will be completed monthly for 3 consecutive months. Subjects will return 4 weeks\n      following the last treatment for follow up photography, measurements, and assessments. This\n      study is a pilot study designed to determine feasibility of these procedures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Female subjects ages 30-65 years old.\n\n          2. Body mass index (BMI) between 18 and 29.99. (BMI is defined as weight in pounds\n             multiplied by 703 divided by the square of the height in inches).\n\n          3. Subjects are in good health.\n\n          4. Willing and able to abstain from partaking in any treatment other than the study\n             procedure (existing or new) to promote body contouring and/or weight loss during the\n             course of study participation.\n\n          5. Subjects agree to maintain their weight (i.e. within 5 pounds) by not making any\n             changes to diet or lifestyle during the study.\n\n          6. The subjects have the willingness and the ability to understand and provide informed\n             consent for the use of their tissue and communicate with the investigator.\n\n        Exclusion Criteria:\n\n          1. Pregnant or lactating or intends to become pregnant in the next 9 months.\n\n          2. Unable to understand the protocol or to give informed consent.\n\n          3. Any previous and/or pending procedures at the treatment area or that may likely\n             affect the treatment area.\n\n          4. Pending and/or anticipated major change in diet or exercise pattern in the six weeks\n             following the last treatment or who has taken diet pills within the last 6 months..\n\n          5. History of asthma or chronic obstructive pulmonary diseases.\n\n          6. Active skin disease or skin infection in the treatment area.\n\n          7. Bleeding tendency or coagulopathy.\n\n          8. Subjects who are allergic to lidocaine.\n\n          9. Any other condition that would, in the professional opinion of the investigator,\n             potentially affect response or participation in the clinical study, or would pose as\n             an unacceptable risk to the subject."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976247", 
            "org_study_id": "STU84032"
        }, 
        "intervention": [
            {
                "arm_group_label": "High Intensity Focused Ultrasound Device", 
                "intervention_name": "High Intensity Focused Ultrasound Device", 
                "intervention_type": "Device", 
                "other_name": "Liposonix"
            }, 
            {
                "arm_group_label": "Noninvasive Cryolipolysis Device", 
                "intervention_name": "Noninvasive Cryolipolysis Device", 
                "intervention_type": "Device", 
                "other_name": "Zeltiq"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 22, 2014", 
        "location": {
            "contact": {
                "email": "research.nuderm@norhtwestern.edu", 
                "last_name": "Emily Poon, PhD", 
                "phone": "312-695-4761"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern University Department of Dermatology"
            }, 
            "investigator": {
                "last_name": "Murad Alam, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pilot Study Comparing the Effectiveness of a Noninvasive Cryolipolysis Device vs. a High Intensity Focused Ultrasound Device for Fat Reduction: A Randomized Control Trial", 
        "overall_contact": {
            "email": "research.nuderm@northwestern.edu", 
            "last_name": "Emily Poon, PhD", 
            "phone": "312-695-4761"
        }, 
        "overall_official": {
            "affiliation": "Northwestern University", 
            "last_name": "Murad Alam, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome was a blinded rating of the treatment area (Noninvasive Cryolipolysis Device vs. a High Intensity Focused Ultrasound Device) with the best cosmetic appearance. A dermatologist will blindly evaluate the treated areas of each side from live subjects at baseline and on the final follow up visit (week 12).", 
            "measure": "Change in best overall cosmetic appearance (right side or left side better)rated by a blinded dermatologist from baseline to week 12", 
            "safety_issue": "No", 
            "time_frame": "1 hour at baseline and week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976247"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northwestern University", 
            "investigator_full_name": "Murad Alam", 
            "investigator_title": "Professor in Dermatology, Otolaryngology - Head and Neck Surgery, and Surgery-Organ Transplantation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}